发明名称 Pyrimidine matrix metalloproteinase inhibitors
摘要 Selective MMP-13 inhibitors are pyrimidine derivatives of the formula or a pharmaceutically acceptable salt thereof, wherein: R2 is hydrogen, halo, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 alkynyl, NO2, NR4R5, CN, or CF3; E is independently O or S; A and B independently are OR4 or NR4R5; R4 and R5 independently are H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, (CH2)n aryl, (CH2)n cycloalkyl, (CH2)n heteroaryl, or R4 and R5 when taken together with the nitrogen to which they are attached complete a 3- to 8-membered ring containing carbon atoms and optionally containing a heteroatom selected from O, S, or NH, and optionally substituted or unsubstituted; n is an integer of from 0 to 6
申请公布号 US2002151555(A1) 申请公布日期 2002.10.17
申请号 US20020075909 申请日期 2002.02.13
申请人 BARVIAN NICOLE CHANTEL;PATT WILLIAM CHESTER 发明人 BARVIAN NICOLE CHANTEL;PATT WILLIAM CHESTER
分类号 A61K31/505;A61K31/506;A61K31/513;A61K31/5377;A61K31/541;A61P9/04;A61P19/02;A61P29/00;A61P35/00;A61P43/00;C07D239/28;C07D401/12;C07D405/12;C07D405/14;C07D409/12;C07D413/14;C07D417/12;C07D417/14;(IPC1-7):C07D417/02;C07D413/02;C0743/02;A61K31/537 主分类号 A61K31/505
代理机构 代理人
主权项
地址